Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 2063 of 5804
-
New prostate cancer combo trial ends early
Disease control TerminatedThis study consists of a dose escalation study with an expansion phase to evaluate the safety, tolerability, pharmacokinetics (PK), and pharmacodynamics (PD), and preliminary efficacy of exicorilant (CORT125281) in combination with enzalutamide in patients with metastatic castrat…
Phase: PHASE1, PHASE2 • Sponsor: Corcept Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
New drug shows promise for lupus and kidney complications
Disease control CompletedThis was a Phase 1b/2, multi-center study in which patients received KZR-616, administered as a subcutaneous (SC) injection weekly for 13 weeks (Phase 1b) or 24 weeks (Phase 2).
Phase: PHASE1, PHASE2 • Sponsor: Kezar Life Sciences, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New anemia pill challenges standard shot for dialysis patients
Disease control CompletedFor hemodialysis subjects currently receiving ESAs with anemia associated with chronic kidney disease, demonstrate non-inferiority of MT-6548 compared to darbepoetin alfa using Hb value and evaluate long-term safety of MT-6548.
Phase: PHASE3 • Sponsor: Tanabe Pharma Corporation • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New vaginal ring aims to give women more birth control choices
Disease control CompletedThis will be a multi-site, open-label, randomized clinical trial. The investigators will randomize 300 eligible participants in a 1:1 ratio to two different treatment regimens that are to be followed when using a contraceptive vaginal ring delivering a daily dose of Nestorone® an…
Phase: PHASE2 • Sponsor: Premier Research • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New methods could spot hidden heart artery disease sooner after transplant
Knowledge-focused OngoingHeart transplantation is an effective life-saving treatment for patients with end-stage heart disease. After a transplant, the new heart may develop narrowing in the arteries, causing heart failure, heart attacks and abnormal heart rhythms. This condition is known as cardiac allo…
Sponsor: Ottawa Heart Institute Research Corporation • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:26 UTC
-
Could a seizure drug soothe IBS belly pain?
Symptom relief CompletedAbdominal pain remains the most deleterious symptom for patients with irritable bowel syndrome (IBS) and is causing a significant alteration of their quality of life. The visceral hypersensitivity seems to be one of the key mechanisms that could explain the abdominal pain in thes…
Phase: PHASE2 • Sponsor: University Hospital, Clermont-Ferrand • Aim: Symptom relief
Last updated Jun 27, 2026 12:23 UTC
-
New DNA test could speed up fungal infection diagnosis in cancer patients
Diagnosis CompletedThe purpose of this study is to evaluate the performances of the real-time PCR ADEMTECH kit of DNA extraction and detection of Aspergillus fumigatus in serum samples in patients at high-risk for invasive aspergillosis (IA). DNA detection will be associated with detection of TR34/…
Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Diagnosis
Last updated Jun 27, 2026 07:58 UTC
-
When to transfuse? study tests best blood strategy for heart patients after surgery
Disease control CompletedThe goal of the proposed study is to determine whether a liberal transfusion strategy (transfusion trigger at Hb \< 10 gm/dl) in Veterans at high cardiac risk who undergo major open vascular and general surgery operations is associated with decreased risk of adverse postoperative…
Phase: NA • Sponsor: VA Office of Research and Development • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
Head-to-Head: which drug works best for sudden joint pain in seniors?
Symptom relief CompletedChondrocalcinosis, recently renamed the calcium pyrophosphate deposition (CPPD) disease, is a very frequent affection of the elderly and causes very painful arthritis. International recommendations for the treatment of patients suffering from CPPD are based upon rare studies, no…
Phase: PHASE3 • Sponsor: Lille Catholic University • Aim: Symptom relief
Last updated Jun 27, 2026 12:09 UTC
-
Big brothers big sisters put to the test: can mentoring prevent crime?
Prevention CompletedThe purpose of this study is to evaluate the effectiveness of the Big Brothers Big Sisters of America (BBBSA) community-based mentoring (CBM) program for prevention of crime and delinquency/conduct problems, including risk and protective factors for these outcomes. Approximately …
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 08:13 UTC
-
New No-Needle permanent birth control could replace surgery
Disease control CompletedProspective, multi-center, international, non-randomized, two-arm study of subjects undergoing either FemBloc or laparoscopic bilateral tubal sterilization (Control). The FemBloc group total study duration will be approximately 65 months. The laparoscopic tubal sterilization (Con…
Phase: NA • Sponsor: Femasys Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:08 UTC
-
Could a shorter radiation course be just as good for endometrial cancer?
Symptom relief Recruiting nowThis randomized phase III trial studies short course vaginal cuff brachytherapy to see how well it works compared with standard of care vaginal cuff brachytherapy in treating participants with stage I-II endometrial cancer. Short course vaginal cuff brachytherapy, also known as i…
Phase: PHASE3 • Sponsor: University of Utah • Aim: Symptom relief
Last updated Jun 27, 2026 08:03 UTC
-
Slip and trip training aims to teach the brain to prevent falls
Disease control Recruiting nowThe objective of this pilot study is to evaluate and compare the effect of three different perturbation based training devices on the reactive balance control among healthy young adults, healthy older adults, and neurologically impaired stroke individuals. Furthermore, the projec…
Phase: NA • Sponsor: University of Illinois at Chicago • Aim: Disease control
Last updated Jul 08, 2026 00:00 UTC
-
Cord injection may curb deadly Post-Birth bleeding
Disease control CompletedThis randomized controlled clinical trial evaluates the effect of umbilical vein injection of oxytocin given in addition to routine active management of the third stage of labour. The third stage of labour is associated with a risk of postpartum haemorrhage, a major cause of mate…
Phase: NA • Sponsor: Dangana Zakari Adeka • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC
-
Can a drug stop the agony of mouth sores during cancer therapy?
Symptom relief CompletedThis is a phase 3, open-label, multicenter, randomized controlled phase III clinical trial. The purpose of this study is to evaluate the efficacy of ulinastatin, a kind of protease inhibitor, in the treatment of radiation-induced acute oral mucositis in localregionally advanced n…
Phase: PHASE3 • Sponsor: Sun Yat-sen University • Aim: Symptom relief
Last updated Jun 27, 2026 12:30 UTC
-
New combo therapy for tough prostate cancer shows promise in early trial
Disease control CompletedThe objective of this study is to determine the maximum safe dose of Ra-223 in combination with fractionated (split doses) docetaxel when given to subjects and to determine the best administering dose. The study will look at side effects that may happen while taking the combinati…
Phase: PHASE1 • Sponsor: Tufts Medical Center • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
Blood test may replace biopsies for breast cancer patients
Knowledge-focused OngoingThe goal of this research study is to determine if we can obtain personalized genetic information from a subject's blood sample that is similar to that obtained from a tumor tissue sample, and if we can use that information to make treatment suggestions.
Phase: NA • Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins • Aim: Knowledge-focused
Last updated Jun 27, 2026 13:04 UTC
-
New drug combo shows promise for Tough-to-Treat bile duct cancer
Disease control CompletedAIO-YMO/HEP-0315 (NIFE) is an open label, non-comparative, randomized, multicenter phase II trial
Phase: PHASE2 • Sponsor: AIO-Studien-gGmbH • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
New hope for hard-to-treat lymphoma: drug combo trial underway
Disease control OngoingThis phase II trial studies how well obinutuzumab with or without umbralisib, lenalidomide, or combination chemotherapy work in treating patients with grade I-IIIa follicular lymphoma that has come back (relapsed) or does not respond to treatment (refractory). Immunotherapy with …
Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Jul 10, 2026 00:00 UTC
-
Could a single dose of sodium oxybate quiet voice tremors?
Symptom relief CompletedUsing a comprehensive approach of clinico-behavioral testing, neuroimaging and pharmacogenetics, the researchers will examine the clinical effects of sodium oxybate and the matched placebo on voice symptoms in spasmodic dysphonia and voice tremor.
Phase: PHASE2, PHASE3 • Sponsor: Kristina Simonyan • Aim: Symptom relief
Last updated Jun 27, 2026 08:07 UTC